« Back
Micropatterned Primary Hepatocyte Co-Cultures for Drug Metabolism and Toxicity Studies
Poster Title: Micropatterned Primary Hepatocyte Co-Cultures for Drug Metabolism and Toxicity Studies
Submitted on 31 Dec 2014
Author(s): Amanda Moore, Chitra Kanchagar, Stacy Krzyzewski, Jeannemarie Gaffney, Julianne Shi, Jack McGeehan and Salman R. Khetani
This poster was presented at SOT 2011
Poster Views: 2,071
View poster »

Poster Information
Abstract: Primary hepatocytes display a precipitous decline in phenotypic functions when cultured in a sandwich of extracellular
matrix proteins (i.e. collagen, Matrigel). We describe a human liver model, HepatoPac TM, with precise microscale cytoarchitecture
and optimal stromal interactions (micropatterned co-cultures) that displays stable functions for several weeks
in vitro. Micropatterned co-cultures were coupled with miniaturization strategies (i.e. 24- and 96-well format) and
optimized for the screening of genotype-specific and clinically-relevant drug disposition. DILI can also be assessed using
standard end-points (i.e. ATP depletion, mitochondrial activity). We have investigated the toxicity of several hepatotoxins
(i.e. Trazodone, Isoniazid, Imipramine etc. ) in our model under both acute and chronic dosing regimens and show
concordance with preclinical and clinical findings. Since metabolism is an important determinant to the overall disposition
of drugs and the profile of metabolites can have an impact on efficacy and safety, the utility of micropatterned co-cultures
for prediction of compound clearance and generation of human metabolites was evaluated. Micropatterned co-cultures
classifies compounds based on rates of clearance and generated metabolites arising from both phase 1 and 2 reactions
(single and sequential). Transporter assays (uptake and efflux) could be performed on micropatterned co-cultures towards
simultaneous assessment of the interplay of drug transport, metabolism, and toxicity. Long-term drug-drug interaction
studies (i.e. enzyme induction and inhibition) have also been explored and results indicate that micropatterned co-cultures
are able to recapitulate clinical outcomes. In the future, miniaturized micropatterned co-cultures may find utility in the
development of several classes of therapeutic compounds (drugs, biologics), in evaluating the injury potential of
environmental toxicants, in fundamental investigations of liver physiology, and in personalized medicine for liver disease.
Summary: A general discussion of HepatoPac, a micropatterned co-culture of hepatocytes and stromal cells for drug metabolism and toxicity studies.References: 1) Khetani, S. R. & Bhatia, S.N. Microscale culture of human liver cells for drug development. Nat Biotechnol. (2007) 26(1): p120-126
2) Khetani, S. R. & Bhatia, S.N. Engineering Tissues for In Vitro Applications. Curr Opin Biotechnol. (2006) 17(15): p524-31
3) Kaplowitz, N. Idiosyncratic drug hepatotoxicity. Nat Rev Drug Discov 4, 489-499 (2005).
4) Schuster D, Laggner C, Langer T. Why drugs fail--a study on side effects in new chemical entities.
5) Olson, H. et al. Concordance of the toxicity of pharmaceuticals in humans and in animals. Regul Toxicol Pharmacol 32, 56-67 (2000).
6) Hewitt, N.J. et al. Primary hepatocytes: current understanding of the regulation of metabolic enzymes and transporter proteins, and
pharmaceutical practice for the use of hepatocytes in metabolism, enzyme induction, transporter, clearance, and hepatotoxicity studies. Drug
Metab Rev 39, 159-234 (2007).
7) Xu, J.J. et al. Cellular Imaging Predictions of Clinical Drug-Induced Li
Report abuse »
Ask the author a question about this poster.
Ask a Question »

Creative Commons